Clinical Trials Sponsored by Pär Johansson

Total 2535 results

Pär Johansson

Completed

Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure (COMBAT-COVID)

COVID-19 | Respiratory Failure

Denmark
Pär Johansson

Not yet recruiting

Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure (COMBAT-ARF)

Endothelial Dysfunction | Acute Respiratory Failure | Pulmonary Infection

Denmark
Pär Johansson

Completed

Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA)

Cardiac Arrest

Denmark
Pär Johansson

Terminated

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis (METSEP)

Endothelial Dysfunction

Denmark
Pär Johansson
Odense University Hospital; Oslo University Hospital; Aarhus University Hospital and other collaborators

Completed

Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure (SHINE-TRAUMA)

Multi Organ Failure

Denmark, Norway
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson

Terminated

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

Refractive Error | Astigmatism | Myopia

Japan
AdventHealth
Johnson & Johnson

Completed

Resilience Intervention for Critical Care Nurses

Stress

United States
AstraZeneca
Johnson & Johnson

Completed

Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy (Kagami_SDS)

Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy

Japan
Johnson & Johnson Pte Ltd
Johnson & Johnson (Hong Kong) Ltd.

Completed

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Pneumonia | Urinary Tract Infections | Pneumonia, Ventilator-Associated

Malaysia, Singapore, Vietnam, Indonesia, Hong Kong
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Johnson & Johnson Medical, China

Completed

China CellSearch Study

Metastatic Breast Cancer | Benign Breast Disease

China
Johnson & Johnson Pte Ltd

Completed

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries (MARCOPOLO)

Plaque Psoriasis

Taiwan, Korea, Republic of, Malaysia, Singapore, Indonesia
Johnson & Johnson Taiwan Ltd

Completed

Pain Satisfaction Survey

Pain
Johnson & Johnson Taiwan Ltd

Completed

Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Taiwan Ltd

Completed

Study on Migraine and Headache in Epileptic Patients

Epilepsy
Johnson & Johnson Taiwan Ltd

Completed

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

Schizophrenia
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Cancer Pain
Johnson & Johnson Taiwan Ltd

Completed

A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma

Multiple Myeloma
Johnson & Johnson Taiwan Ltd

Completed

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Pain
Johnson & Johnson Taiwan Ltd

Completed

A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
Vita Care
Johnson & Johnson

Recruiting

ACL Reconstruction With Simple and Double Bundle Technique Using Two Different Implants for Graft Fixation

Knee Injuries | ACL Injury | Sports Injury | ACL Tear

Brazil
Johnson & Johnson Medical, China

Completed

OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China

Blood Glucose Measurement

China
Johnson & Johnson Private Limited

Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

Multiple Myeloma

India
Johnson & Johnson Pte Ltd

Terminated

A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (RISE)

Human Immunodeficiency Virus Infections

India
Austin Eye
Johnson & Johnson

Completed

Symfony Intraocular Lens Retrospective Chart Review

Cataract
Johnson & Johnson Private Limited

Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Klinikum Fulda
Johnson & Johnson

Completed

Standardization of Laparoscopic Hernia Repair (LIPOM)

Incisional Hernia

Germany
Johnson & Johnson Taiwan Ltd

Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Multiple Myeloma

Taiwan
Johnson & Johnson Pte Ltd

Completed

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia (CONSIST)

Constipation

China, Malaysia, Korea, Republic of, Singapore, Philippines
Johnson & Johnson Pte Ltd

Completed

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia (PREVAIL)

Schizophrenia

China, Taiwan, Malaysia, Korea, Republic of
Johnson & Johnson Taiwan Ltd

Completed

The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
Johnson & Johnson Pte Ltd

Completed

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

Schizophrenia

Australia, China, Hong Kong, Taiwan, Malaysia, Korea, Republic of, New Zealand, Thailand, Philippines
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Schizophrenia | Schizoaffective Disorders
Johnson & Johnson Taiwan Ltd

Completed

A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia

Schizophrenia
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Taiwan
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain

Pain | Fibromyalgia
Johnson & Johnson Medical, China

Terminated

Care China-Diabetes

Cardiovascular Disease | Diabetes

China
Johnson & Johnson Medical, China

Terminated

GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study

Breast Cancer

China
Johnson and Johnson, S.A.

Completed

Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent

Coronary Arteriosclerosis

Spain, Portugal
Johnson & Johnson Taiwan Ltd

Completed

Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

Acne Vulgaris
Johnson & Johnson Taiwan Ltd

Completed

Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

Attention Deficit Disorder With Hyperactivity
Southern Health
Johnson & Johnson

Unknown

Are Sutures Required for Vaginal Hysterectomy: A Randomized Controlled Trial (HAVE)

Vaginal Hysterectomy

Australia
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Diabetes Mellitus

India
Johnson & Johnson Private Limited

Completed

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Arthritis, Psoriatic | Spondylitis, Ankylosing

India
Johnson & Johnson Private Limited

Withdrawn

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostate Cancer

India
Johnson & Johnson Private Limited

Completed

A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting

Diabetes Mellitus, Type 2

India
Johnson & Johnson Medical, China

Completed

Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China

Atrial Fibrillation
DePuy International
Johnson & Johnson

Terminated

Multi-centre Study to Assess Long-term Safety and Efficacy of the Silent™ Hip Prosthesis in Primary THR

Osteoarthritis

United Kingdom, Australia, France, Germany, Italy
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Schizophrenia

Taiwan
Dermatrials Research
Johnson & Johnson

Completed

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Acne

Canada

3

Subscribe